Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2025 investor ...

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” first quarter 2025 investor letter.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories (BIO – Research Report) on April 1 and set a price target of ...

Bio-Rad Laboratories, Inc.’s BIO Clinical Diagnostics business is back to its usual growth trajectory post-pandemic while maintaining a strong market position worldwide for key platforms.

Low commission rates start at $0 for U.S. listed stocks & ETFs*. Margin loan rates from 4.83% to 5.83%. Commission-free trading on stocks & ETFs. Earn $+0.06 per options contract and 5.1% APY on ...

The microbiology culture market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving growth ...

TC20 Automated Cell Counter from Bio-Rad Whole Gel Eluter and Mini Whole Gel Eluter from Bio-Rad High Credibility: This website adheres to all nine standards of credibility and transparency.

Led by Friends, collaborators included Biodesix alongside organizations from industry, government, academia, and advocacy ...

Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life ...